These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31484694)

  • 1. Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling.
    Kwong SC; Jamil AHA; Rhodes A; Taib NA; Chung I
    J Lipid Res; 2019 Nov; 60(11):1807-1817. PubMed ID: 31484694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE.
    Kwong SC; Abd Jamil AH; Rhodes A; Taib NA; Chung I
    Biochimie; 2020 Dec; 179():23-31. PubMed ID: 32931863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.
    Liu RZ; Graham K; Glubrecht DD; Lai R; Mackey JR; Godbout R
    J Pathol; 2012 Nov; 228(3):310-21. PubMed ID: 22322885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
    Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
    BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of FABP7 in tumor cell signaling.
    Kagawa Y; Umaru BA; Ariful I; Shil SK; Miyazaki H; Yamamoto Y; Ogata M; Owada Y
    Adv Biol Regul; 2019 Jan; 71():206-218. PubMed ID: 30245263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.
    Mita R; Beaulieu MJ; Field C; Godbout R
    J Biol Chem; 2010 Nov; 285(47):37005-15. PubMed ID: 20834042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
    Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
    Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of FABP7 inhibits acute kidney injury-induced TCMK-1 cell apoptosis via activating the PPAR gamma signalling pathway.
    Xu D; Shen L; Zhou L; Sha W; Yang J; Lu G
    Mol Omics; 2020 Dec; 16(6):533-542. PubMed ID: 33315023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells.
    De Rosa A; Pellegatta S; Rossi M; Tunici P; Magnoni L; Speranza MC; Malusa F; Miragliotta V; Mori E; Finocchiaro G; Bakker A
    PLoS One; 2012; 7(12):e52113. PubMed ID: 23284888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of fatty acid binding protein 7 and its effect on fatty acid of renal cell carcinoma cell lines.
    Takaoka N; Takayama T; Ozono S
    BMC Cancer; 2017 Mar; 17(1):192. PubMed ID: 28292269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress.
    Cheng A; Wang YF; Shinoda Y; Kawahata I; Yamamoto T; Jia WB; Yamamoto H; Mizobata T; Kawata Y; Fukunaga K
    Acta Pharmacol Sin; 2022 Mar; 43(3):552-562. PubMed ID: 33935286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human brain-type fatty acid-binding protein FABP7 complexed with palmitic acid.
    Nam KH
    Acta Crystallogr D Struct Biol; 2021 Jul; 77(Pt 7):954-965. PubMed ID: 34196621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding FABP7 binding to fatty acid micelles and membranes.
    Lenz S; Bodnariuc I; Renaud-Young M; Butler TM; MacCallum JL
    Biophys J; 2023 Feb; 122(4):603-615. PubMed ID: 36698315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
    Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
    Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation.
    Umaru BA; Kagawa Y; Ohsaki Y; Pan Y; Chen CT; Chen DK; Abe T; Shil SK; Miyazaki H; Kobayashi S; Maekawa M; Yamamoto Y; Wannakul T; Yang S; Bazinet RP; Owada Y
    FEBS J; 2023 Apr; 290(7):1798-1821. PubMed ID: 36325660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.
    Liu J; Liu L; Yagüe E; Yang Q; Pan T; Zhao H; Hu Y; Zhang J
    Breast Cancer Res Treat; 2019 Feb; 174(1):65-78. PubMed ID: 30450530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
    Camarda R; Zhou AY; Kohnz RA; Balakrishnan S; Mahieu C; Anderton B; Eyob H; Kajimura S; Tward A; Krings G; Nomura DK; Goga A
    Nat Med; 2016 Apr; 22(4):427-32. PubMed ID: 26950360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.